Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antibiotic usage in Nordic countries.

T Bergan1

  • 1Institute of Medical Microbiology, Kaptein W. Wilhelmsen of Frues, University of Oslo, Rikshospitalet, Oslo 0027, Norway. tom.bergan@labmed.uio.no

International Journal of Antimicrobial Agents
|October 24, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

On the occurrence of radioactive fallout over Norway as a result of the Windscale accident, October 1957.

Journal of environmental radioactivity·2007
Same author

Introduction: Parameters for prevention of post-operative infections.

Journal of chemotherapy (Florence, Italy)·2002
Same author

Chelating agents.

Chemotherapy·2000
Same author

Ground penetrating radar surveys to locate 1918 Spanish flu victims in permafrost.

Journal of forensic sciences·2000
Same author

Vaginal disinfection with chlorhexidine during childbirth.

International journal of antimicrobial agents·1999
Same author

Preparation and antimicrobial studies of acyclic sulfamates.

Acta chemica Scandinavica (Copenhagen, Denmark : 1989)·1999
Same journal

Strain-dependent variability in pharmacodynamic interactions for phage-antibiotic combinations in Pseudomonas aeruginosa.

International journal of antimicrobial agents·2026
Same journal

Carbapenem-resistant Enterobacterales across the UK: a nationwide study of carbapenemase testing and novel antimicrobial activity.

International journal of antimicrobial agents·2026
Same journal

Kidney Injury, Dialysis, and Mortality with Vancomycin Plus Piperacillin-Tazobactam or Cefepime.

International journal of antimicrobial agents·2026
Same journal

Ceftaroline pharmacokinetics on ECMO, a pediatric case report.

International journal of antimicrobial agents·2026
Same journal

In reply to the Letter to Editor regarding "Comment on "Development and validation of a predictive model for profiling antibiotic resistance phenotypes of Acinetobacter baumannii strains via clinical MALDI-TOF mass spectra: A multicenter study".

International journal of antimicrobial agents·2026
Same journal

Comment on "Targeting the human protein disulfide isomerase A3 as a broad-spectrum antiviral approach against human respiratory viruses".

International journal of antimicrobial agents·2026
See all related articles

Antibacterial consumption in Scandinavia is low and stable, with Iceland and Finland showing the highest use. This contrasts with other regions, contributing to higher antibiotic susceptibility in Nordic countries.

Area of Science:

  • Pharmacology
  • Infectious Diseases
  • Public Health

Background:

  • Antibacterial consumption varies globally, impacting treatment efficacy.
  • Nordic countries have historically maintained lower antibacterial use compared to other regions.
  • Understanding antimicrobial prescribing patterns is crucial for combating resistance.

Purpose of the Study:

  • To analyze and compare antibacterial consumption patterns across Scandinavian countries.
  • To investigate the distribution of different antimicrobial classes within these nations.
  • To evaluate the correlation between prescribing policies and antibiotic susceptibility.

Main Methods:

  • Data collection on antibacterial consumption using Defined Daily Doses (DDD).
  • Comparative analysis of DDDs across Iceland, Finland, Sweden, Denmark, and Norway.

Related Experiment Videos

  • Examination of the proportions of specific antimicrobial classes, including penicillins, fluoroquinolones, and cephalosporins.

    • Main Results:

    • Overall antibacterial consumption is low and stable in Scandinavia, with highest DDDs in Iceland and Finland, and lowest in Denmark and Norway.
    • Significant variations exist in antimicrobial class distribution; phenoxymethyl/benzylpenicillin dominate in Sweden, Denmark, and Norway, while narrow-spectrum penicillins are prominent in Iceland.
    • Fluoroquinolone use is minimal, except in Sweden (10%), and cephalosporin use ranges from 1% (Denmark) to 15% (Finland).

    Conclusions:

    • The Scandinavian region demonstrates distinct antibacterial consumption profiles.
    • A policy favoring narrow-spectrum penicillins and limiting broad-spectrum agents contributes to higher antibiotic susceptibility in Nordic countries.
    • These findings underscore the importance of targeted antimicrobial stewardship to preserve treatment effectiveness.